Found 11 matching trials
HAIC + DEB-TACE + Toripalimab + Lenvatinib for Unresectable Intrahepatic Cholangiocarcinoma
PHASE2Purpose: This phase II clinical trial evaluates whether a combination of li...
Location
Multiple Locations
HAIC Sequential TAE Combined With Lenvatinib and Tislelizumab in Unresectable HCC
PHASE2Patients with unresectable hepatocellular carcinoma will receive hepatic ar...
Location
Guangxi Medical University Cancer Hospital
Concurrently vs Sequentially Combined HAIC With Targeted and Immunotherapy in Potentially Resectable HCC
PHASE3The goal of this clinical trial is to compare HAIC concurrently with sequen...
Location
SUN Yat-sen University Cancer Center
Triple Therapy Sequential Radiotherapy in Unresectable HCC (TALENP003)
N/AThis is an Open-label, Multicenter, Phase II clinical trial to evaluate the...
Location
First Affiliated Hospital of Fujian Medical University
bTAE-HAIC Combined With Lenvatinib and Sintilimab for Infiltrative Hepatocellular Carcinoma
NAThis study intends to evaluate the efficacy and safety of blank- microspher...
Location
Sun Yat-sen University Cancer Center
TACE Combined With Lenvatinib Versus TACE Sequential Lenvatinib in the Treatment of Intermediate/Advanced Liver Cancer
PHASE3TACE(transcatheter arterial chemoembolization) has been recommended by dome...
Location
Department of Minimally Invasive and Interventional Radiology, Liver Cancer Study and Service Group, Sun Yat-sen University Cancer Center,
Cabozantinib as Subsequent Therapy to an Immune Checkpoint Based Therapy in Renal Cell Carcinoma
PHASE2This study is a phase 2, multicenter, interventional for cohort 1 \& 2, non...
Location
Asan Medical Center
bTAE-HAIC Combined With System Therapy for Intermediate-advanced Huge HCC
NAThis study intends to evaluate the efficacy and safety of blank- microspher...
Location
Sun Yat-sen University Cancer Center
Rapid Sequencing of Approved Therapies in Patients With Metastatic or Unresectable Clear Cell Renal Cell Carcinoma
EARLY_PHASE1This is a pilot, single-center, single-arm study where 20 patients with met...
Location
Icahn School of Medicine at Mount Sinai
Sequential PD-1/PD-L1 Inhibitor and LENvatinib in TLCT and Refractory Hepatoblastoma After Chemotherapy
PHASE2This is a single arm, open-label trial studying the combination of PD-1/PD-...
Location
Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong University